Instituto do Cerebro do Rio Grande do Sul

Porto Alegre, Rio Grande do Sul 90610-000

2 studies enrolling now · 5 studies all time

What they study most

Alzheimer's Disease, Alzheimers Disease, Multiple Sclerosis, Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD)

Studies at this site

• A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease — Recruiting now
• Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies — Recruiting now
• A Study to Assess Bioequivalence of Two Subcutaneous (SC) Formulations of Ocrelizumab in Participants With Multiple Sclerosis (MS) — Running, not enrolling
• A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Participants With Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease — Running, not enrolling
• A Study to Verify the Clinical Benefit of Aducanumab in Participants With Early Alzheimer's Disease — Stopped early